Cybersecurity patches — both proactive to address potential threats and reactive to respond to threats that have already occurred — can be expected to be part of any connected device’s lifecycle. But in the medical device world, these patches constitute design changes, which are strictly regulated, says Eric Henry, a senior quality systems and compliance adviser in the law firm King & Spalding.
Source: Drug Industry Daily